DE60019914D1 - Verwendung von Sibutramin oder dessem Derivat zur Behandlung von Schlafstörungen - Google Patents

Verwendung von Sibutramin oder dessem Derivat zur Behandlung von Schlafstörungen

Info

Publication number
DE60019914D1
DE60019914D1 DE60019914T DE60019914T DE60019914D1 DE 60019914 D1 DE60019914 D1 DE 60019914D1 DE 60019914 T DE60019914 T DE 60019914T DE 60019914 T DE60019914 T DE 60019914T DE 60019914 D1 DE60019914 D1 DE 60019914D1
Authority
DE
Germany
Prior art keywords
sibutramine
derivative
treatment
sleep disorders
snoring
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60019914T
Other languages
English (en)
Other versions
DE60019914T2 (de
Inventor
Crawford Cheetham
John Heal
M Mendel
B Seaton
P Weinstein
Anton Safer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott GmbH and Co KG
Original Assignee
Abbott GmbH and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott GmbH and Co KG filed Critical Abbott GmbH and Co KG
Application granted granted Critical
Publication of DE60019914D1 publication Critical patent/DE60019914D1/de
Publication of DE60019914T2 publication Critical patent/DE60019914T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Anesthesiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Harvester Elements (AREA)
  • Fluid-Pressure Circuits (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE60019914T 1999-03-19 2000-03-17 Verwendung von Sibutramin oder dessem Derivat zur Behandlung von Schlafstörungen Expired - Fee Related DE60019914T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12518599P 1999-03-19 1999-03-19
US125185P 1999-03-19
PCT/US2000/007177 WO2000056314A1 (en) 1999-03-19 2000-03-17 Method of treating sleep apnoea

Publications (2)

Publication Number Publication Date
DE60019914D1 true DE60019914D1 (de) 2005-06-09
DE60019914T2 DE60019914T2 (de) 2006-05-04

Family

ID=22418567

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60019914T Expired - Fee Related DE60019914T2 (de) 1999-03-19 2000-03-17 Verwendung von Sibutramin oder dessem Derivat zur Behandlung von Schlafstörungen

Country Status (26)

Country Link
US (1) US6365631B1 (de)
EP (1) EP1169029B1 (de)
JP (1) JP2003521469A (de)
KR (1) KR100682291B1 (de)
CN (1) CN1161114C (de)
AT (1) ATE294573T1 (de)
AU (1) AU773489B2 (de)
BG (1) BG106001A (de)
BR (1) BR0009080A (de)
CA (1) CA2367022A1 (de)
CZ (1) CZ298293B6 (de)
DE (1) DE60019914T2 (de)
DK (1) DK1169029T3 (de)
ES (1) ES2244420T3 (de)
HK (1) HK1044462B (de)
HU (1) HUP0200501A3 (de)
IL (2) IL145244A (de)
MX (1) MXPA01009464A (de)
NO (1) NO20014475L (de)
NZ (1) NZ514014A (de)
PL (1) PL359467A1 (de)
PT (1) PT1169029E (de)
SI (1) SI1169029T1 (de)
SK (1) SK285308B6 (de)
WO (1) WO2000056314A1 (de)
ZA (1) ZA200107678B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6974838B2 (en) 1998-08-24 2005-12-13 Sepracor Inc. Methods of treating or preventing pain using sibutramine metabolites
US6476078B2 (en) 1999-08-11 2002-11-05 Sepracor, Inc. Methods of using sibutramine metabolites in combination with a phosphodiesterase inhibitor to treat sexual dysfunction
US6399826B1 (en) 1999-08-11 2002-06-04 Sepracor Inc. Salts of sibutramine metabolites, methods of making sibutramine metabolites and intermediates useful in the same, and methods of treating pain
WO2002083631A1 (en) 2001-04-13 2002-10-24 Sepracor Inc. Methods of preparing didesmethylsibutramine and other sibutramine derivatives
JP4278652B2 (ja) * 2002-10-05 2009-06-17 ハンミ ファーム． シーオー．， エルティーディー． 結晶性シブトラミンメタンスルホン酸塩半水和物を含む医薬組成物
US20050131074A1 (en) * 2003-08-04 2005-06-16 Beckman Kristen M. Methods for treating metabolic syndrome
US20050228052A1 (en) * 2004-01-29 2005-10-13 Barberich Timothy J Methods of treating, preventing and managing a sleep disorder using (S)-didesmethylsibutramine
ES2337700T3 (es) 2004-02-18 2010-04-28 Sepracor, Inc. Terapia combinada de agonista de dopamina con sedantes para mejorar la calidad del sueño.
KR100627687B1 (ko) * 2005-04-20 2006-09-25 주식회사 씨티씨바이오 시부트라민 유리염기 함유 조성물 및 이의 제조방법
KR20080046601A (ko) * 2006-11-22 2008-05-27 에스케이케미칼주식회사 보관안정성이 우수한 시부트라민 함유 포접복합체

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8531071D0 (en) * 1985-12-17 1986-01-29 Boots Co Plc Therapeutic compound
IE61928B1 (en) * 1988-11-29 1994-11-30 Boots Co Plc Treatment of obesity
US5356934A (en) * 1990-03-29 1994-10-18 Eli Lilly And Company Selected serotonin subtype receptor agonist to treat sleep apnea
US5459164A (en) * 1994-02-03 1995-10-17 Boots Pharmaceuticals, Inc. Medical treatment

Also Published As

Publication number Publication date
IL145244A0 (en) 2002-06-30
HUP0200501A2 (en) 2002-08-28
EP1169029A4 (de) 2004-01-21
NO20014475L (no) 2001-11-14
PL359467A1 (en) 2004-08-23
CZ20013280A3 (cs) 2002-07-17
CN1161114C (zh) 2004-08-11
BR0009080A (pt) 2002-02-13
WO2000056314A1 (en) 2000-09-28
SK285308B6 (sk) 2006-10-05
HK1044462B (zh) 2006-03-03
BG106001A (en) 2002-06-28
CN1356897A (zh) 2002-07-03
ATE294573T1 (de) 2005-05-15
SI1169029T1 (sl) 2005-12-31
EP1169029B1 (de) 2005-05-04
CZ298293B6 (cs) 2007-08-15
PT1169029E (pt) 2005-08-31
CA2367022A1 (en) 2000-09-28
DE60019914T2 (de) 2006-05-04
DK1169029T3 (da) 2005-08-29
HUP0200501A3 (en) 2004-03-29
JP2003521469A (ja) 2003-07-15
US6365631B1 (en) 2002-04-02
MXPA01009464A (es) 2004-03-19
ZA200107678B (en) 2003-06-18
NO20014475D0 (no) 2001-09-14
KR20010113847A (ko) 2001-12-28
IL177626A0 (en) 2006-12-31
AU773489B2 (en) 2004-05-27
NZ514014A (en) 2004-02-27
SK13382001A3 (sk) 2002-04-04
AU3896800A (en) 2000-10-09
ES2244420T3 (es) 2005-12-16
EP1169029A1 (de) 2002-01-09
HK1044462A1 (en) 2002-10-25
KR100682291B1 (ko) 2007-02-15
IL145244A (en) 2006-12-10

Similar Documents

Publication Publication Date Title
IL177626A0 (en) Pharmaceutical compositions for treating sleep apnoea
DE60039508D1 (de) Methoden zur behandlung der essstörungen
HK1028599A1 (en) Crystal modification of a n-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use
NO20021328L (no) Pyrazolopyrimidier som terapeutiske midler
DE60133389D1 (de) Gabapentinanaloga für schlafstörungen
NO20052698L (no) 4(fenylpiperazinyl-metyl)benzamid-derivater og deres anvendelse ved behandling av smerte og gasatrintestinale lidelser.
DE60312736D1 (de) 1,2,4-triaminobenzolderivate zur behandlung von erkrankungen des zentralnervensystems
NO991425D0 (no) Medisinsk behandling
ATE390130T1 (de) Verwendung von inhibitoren des kqt1-kanals zur herstellung eines medikaments zur behandlung von krankheiten, die durch helminthen und ektoparasiten hervorgerufen werden
WO2000056315A8 (en) Treatment of pain
DE60117122D1 (de) Verwendung von mirtazapin zur behandlung von schlafstörungen
BG105999A (en) Treatment of osteoarthritis
MXPA01009468A (es) Tratamiento de hipertension pulmonar.
MXPA01009463A (es) Tratamiento de hernia hiatial.
RU2002130223A (ru) Фитопрофилактика стресса у цыплят-бройлеров
TH18470B (th) อนุพันธ์เมลาโทนินสำหรับใช้ในการรักษาความผิดปกติของการหลับ

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee